The General Pharmaceutical Council (GPHC), Royal Pharmaceutical Society (RPS), Company Chemists Association (CCA), Association of Pharmacy
Technicians UK (APTUK), National Pharmacy Association (NPA), Guild of Healthcare Pharmacists, Pharmacists' Defence Association (PDA), and Independent
Pharmacies Association (IPA) have released a joint statement in response to the far-right riots across the UK.
They emphasised their united stance, declaring zero tolerance for racism towards colleagues or the public in any form.
The joint statement reads: "We are shocked and saddened by the violent public disorder events in recent days.
"We acknowledge how all sectors of the pharmacy profession may be impacted and recognise the challenges that this level of overt aggression can have on
people's ability or willingness to live their daily lives.
"The pharmacy workforce deserves peace and safety, not fear and harm. We stand united in having a zero tolerance of racism towards our colleagues or the
public in whatever form it takes."
Meanwhile, Community Pharmacy England (CPE) has expressed concerns that protests and violent disorder in various towns and cities across England may impact
the ability of community pharmacies to operate.
In a powerful display of unity, thousands of pharmacies across the UK participated in a nationwide protest today, organised by the National Pharmacy
Association (NPA), as part of its #saveourpharmacies campaign.
The NPA's day of action was aimed at drawing attention to the severe crisis in pharmacy funding that has forced 1,400 pharmacies to close over the past decade
and left thousands more struggling.
Participating pharmacies showed their protest through various actions like dimming lights, blacking out their windows, wearing black for the day, or discussing
pharmacy funding with customers. Many pharmacies also seized the opportunity to interact with parliamentary candidate, urging them to address the funding crisis.
The Pharmacy Supervision Practice Group consisting of members from AIMp, APTUK, CCA, NPA, PDA, PFNI and RPS held its fourth workshop to continue discussions
on the future modelling of pharmacy practice.
The ideas around 'supervision' shared by the organisation earlier formed the basis of the discussion during the workshop and helped to expand understanding of where
there was consensus and disagreement.
Examples of ideas explored during the workshop include: the extent to which a pharmacist should supervise the medicines assembly process, the purpose and extent to
which a pharmacist might be absent from the pharmacy and how this might affect patient safety as well as the nature of whether fixed rules versus a broad framework
were preferable for future practice.
Chair of the group, Dr Michael Twigg, Associate Professor of Primary Care Pharmacy, University of East Anglia, said "Once again the sector bodies have come together
in a collaborative and positive manner to explore the concept of 'supervision' in the context of current and future community pharmacy practice. This session provided an opportunity to constructively challenge assumptions and viewpoints within the group with the aim of moving the discussion forward."
As part of the session, the DHSC, GPhC and PSNI gave an overview of the difference between legislation, regulation and guidance which was helpful to inform the
group's thinking. Each of the organisations have been asked to use the conversation to refine the ideas presented in advance of the next workshop.
The trade bodies and four largest pharmacy chains in England, have jointly written to the Secretary of State for Health, Steve Barclay, warning that the sector
needs urgent investment for sustainability.
The letter from AIMp, CCA, NPA, PSNC, Boots UK, Lloyds Pharmacy, Well, and Phoenix UK, warned that the 30 per cent real terms funding cuts that pharmacies have faced
over the past seven years have left many businesses in a cashflow crisis.
The letter said that the government is facing a choice over the future of the country's 11,000+ community pharmacies, with permanent closures likely and medicines
supply at risk if no urgent action is taken.
"If the funding situation is not addressed, the sector is likely to move rapidly towards many permanent closures of pharmacies."
The organisations say that once these closures start, they will be hard to stop, as the sector is now so fragile other pharmacies would struggle to pick up the slack.
Former superintendent pharmacist and National Pharmacy Association (NPA) director, Phil Galt, has been appointed the new UK managing director for pharmacy
software supplier Cegedim Rx.
The position was previously held by Adam Dennett, who resigned after a successful ten-year tenure to pursue a new career outside healthcare, the company said.
Cegedim Rx, the pharmacy entity of Cegedim Healthcare Solutions UK, announced the new appointment this month (April 5).
Tristan de Foucher, head of European operations for Cegedim Group, said: "Adam has been a force of nature in this business for the past 10 years. Under his
leadership, the team has continuously and successfully invested in and driven product innovation to stay ahead of the ever-changing demands placed upon community
pharmacy."
Galt has over 20 years of experience as a qualified pharmacist and a successful business leader. He has worked extensively in community pharmacy, focusing on
both care delivery and technology implementation.
After the government announced to award pay rise to pubic sector workers, pharmacy trade bodies have expressed their disappointment at the neglect shown
towards funding crisis in community pharmacy.
The National Pharmacy Association (NPA) chair, Andrew Lane, said: "Our sector can't help but feel utterly neglected after seven years of crushing real terms cuts
to pharmacy funding, amounting to half a billion pounds, and no hint of any relief to come.
"This week's public sector pay awards, which include a large number of our health service colleagues, highlight that there's an unresolved funding crisis in
community pharmacy which needs urgent attention."
"Four months into this financial year, there is as yet no clarity even on current arrangements."
"After stepping up to tackle Covid and keep the wheels on the NHS, the sector deserves better than to be neglected in this way," Andrew opines.
A recent survey conducted by YouGov for the National Pharmacy Association (NPA) has highlighted concerning trends in the community pharmacy sector.
The survey published on July 18 and conducted over two days in June this year reveals the subsequent challenges patients face due to the increasing pharmacy
closure rates.
The survey findings, conducted among 2,183 UK adults, indicates that 18 per cent of the respondents reported at least one pharmacy closure in their local area
within the past year.
Specifically, 12 per cent respondents noted closure of one pharmacy, while 6 per cent observed the shutdown of more than one.
These closures are distributed across various regions, underscoring a nationwide issue rather than an isolated one.
MCAN Health, a medical travel company based in Istanbul-Turkey, has announced its sponsorship of National Pharmacy Association (NPA), a not-for-profit
organisation representing independent community pharmacies across the UK.
Gulsultan Dogan, the Founder and CEO of MCAN Health, said that their company is dedicated to improving global healthcare accessibility, which aligned perfectly
with the NPA's mission to boost community health services in the United Kingdom.
On receiving the invitation letter from the NPA, Dogan said: "We did not hesitate to show our support and positively answer the invitation letter.
"As a professional in the healthcare sector for years, I firmly believe medical care is a human right that should be accessible to everyone without enduring
lengthy waiting lists."
Northern Ireland's chief pharmaceutical officer paid a visit to a community pharmacy in Belfast on Monday (November 7) - marking the end of this year's Ask
Your Pharmacist week, an annual public awareness campaign launched by the National Pharmacy Association.
Cathy Harrison interacted with patients and staff in the pharmacy before recording a video to promote NI's 'Pharmacy First' service in which she described community
pharmacies as "one of the front doors to the health service" with over 500 outlets located across the country.
"In our community pharmacies you can always rely on friendly staff, medicines expertise, and walk-in access to face-to-face advice," she said.
First launched in Scotland, the NHS Pharmacy First service enables patients to have a consultation with a pharmacist for advice on minor ailments.
Ms Harrison also drew attention to community pharmacy's role in cancer awareness and helping people to quit smoking, as well as managing patients with urinary tract
infections, in addition to playing their part in delivering Covid-19 and flu vaccinations.
Community pharmacy bodies have said that the current crippling financial pressures and severe staff shortages will limit the sector from fully supporting the
new health secretary's ambition to improve patient care in England.
Thérèse Coffey announced her plans on Thursday (September 22) which would be looking to reduce the country's reliance on general practice by expanding the range of
services available from community pharmacies and allowing pharmacists more "prescribing powers".
"Pharmacists will be able to manage and supply more medicines, without a prescription from a GP. We will look to go further on enabling pharmacists with more
prescribing powers and making more simple diagnostic tests available in community pharmacy," she said in her foreword to Our Plan for Patients.
However, the National Pharmacy Association has lamented that the plan stops short of promising any fresh funding for community pharmacies to deliver patient care
and develop clinical services.
NPA vice-chair, Nick Kaye, said: "The life is being choked out of independent pharmacy businesses by the continuation of a fundamentally under-resourced contract
in England.
The One Show on BBC One has put community pharmacy in the limelight, showcasing the sector's vital work during the pandemic to a primetime TV audience.
The five minute segment, aired on May 10, featured Sutton pharmacist Reena Barai and a reception at St. James's Palace for around 200 pharmacists, including Barai,
hosted by the Prince of Wales on May 4.
"It was great to be part of such a positive story," Barai, who is a board member of the National Pharmacy Association (NPA), said.
"It's heartening that the national media are taking notice of the sector, because it's too often overlooked. Coverage like this both reflects public opinion and shapes it, that's why the NPA works so hard on keeping us in the public eye."
The segment told the story of community pharmacy's role during the pandemic and contained footage of a speech by the Prince of Wales, praising the sector for its
contribution to the nation's healthcare.
"Pharmacists are about people and places, not just pills, a place where science, as it were, meets society. I just want to thank you all, more than I can possibly say, for everything you do so brilliantly to keep people well, and above all, save lives. Thank you, everybody," Prince Charles is seen saying at the reception.
We're approaching that time of year where the sun is supposed to be shinning and things are supposed to quieten down over the summer holidays
(note I said supposed to. . . well we have the sun at least).
The elections are over, and a new party is in power. Wes Streeting is the Secretary of State for Health and Social Care. He's met with GPs and Dentists and has
great ambitions for Primary Care but when will he meet with community pharmacists?
To be fair to Wes, he did visit a local pharmacy in his constituency, with CPNEL last year as Shadow Health Secretary (and was a guest speaker at the Pharmacy
Business Awards 2023). He has also had meetings with NPA and CPE, so we know he understands the value of Community Pharmacy. The question is, do we as a sector
and profession need to shout louder so that we aren't forgotten about, as healthcare plans are being drawn up?
Community Pharmacy is a humble sector, not unlike most other HC sectors. The difference is that we often get forgotten. I have lost count of the times I've heard
in meetings or conversations "Primary care and community pharmacy. . ." totally disregarding the fact that we are part of primary care.
The National Pharmacy Association (NPA) has asked the Secretary of State for Health and Social Care to convene a 'medicines supply taskforce', following weeks
of problems with antibiotics supplies.
The NPA's chief executive Mark Lyonette wrote a letter to Steve Barclay this week. It cited the precedent of the HRT Taskforce which this summer brought together
representatives from across the supply chain after months of supply problems affecting women.
"We strongly believe that this situation calls for a similar response from the government. It is imperative that we resolve this supply situation urgently and
therefore we request that you convene a Medicines Supply Taskforce, with all the relevant stakeholders in the supply chain, to urgently discuss and agree practical
solutions to address the disruptions to the supply of medicines. HRT and antibiotics are the most visible examples of a wider problem with medicines supply
which needs to be addressed."
NPA board members Olivier Picard and Reena Barai were among the stakeholders joining meetings convened by the HRT Taskforce this summer.
David Webb, the Chief Pharmaceutical Officer for England, acknowledged that the "pressure in the system is high", but urged everyone to "keep our eye on the
design" of the NHS plan, adding that the "the objective is to bring the different parts of primary care together" in the patient interest.
Speaking during the opening keynote session at the the National Pharmacy Association (NPA) conference held on Thursday (13 October), he added that the NHS plan
intends to bring different parts of primary care together to help patients.
He said the new integrated care boards (ICBs) are a key strategic framework as they provide the "potential to form partnerships to deliver integrated services across
larger populations".
"ICBs will want to work with Local Pharmaceutical Committees to plan for the local population and the new community pharmacy clinical leads in ICBs, who have been
funded by NHS England, are there to advise."
He explained that once an ICB takes over the commissioning of pharmaceutical services (which they are all due to do by April 2023), it could use its funds to
commission a local enhanced service as an add on to an advanced service. For instance, a CVD risk assessment could be added to the blood pressure check service.
Health secretary Sajid Javid vouches support for a "pharmacy first" model of care for minor illnesses, to help clear the backlog of NHS care arising due to
the Covid-19 pandemic.
Speaking at the National Pharmacy Association's (NPA) centenary dinner in central London on Wednesday (November 24), Javid said he wanted to "go further" than existing services like the NHS Community Pharmacist Consultation Service, to make it "quicker and easier" for people to access primary care.
He said: "I want to see how much further we can go. That's one of the reasons why we're working up plans for a pharmacy first model in England that will direct more patients directly to pharmacies without having to go to see their GPs. This will help us to beat the backlog and make sure that even more people can benefit from (pharmacists') brilliant advice and care."
Expressing his commitment to transform every aspect of health and care in the country he said that community pharmacies should be "at the very heart of primary
care - not just treating people but preventing people from becoming patients in the first place."
Jackie Giltrow and Jose Moss have been appointed as Chair and Vice-Chair of the Community Pharmacy Patient Safety group, respectively, bringing with them a
wealth of experience and expertise in pharmacy practice.
Supported by the National Pharmacy Association (NPA) and hosted by the Company Chemists' Association (CCA), the CPPSG serves as a collaborative platform for large
community pharmacy organisations to openly share and learn from each other's experiences.
A CPPSG Chair now, Jackie Giltrow, Clinical Governance Lead at Paydens Limited is a seasoned pharmacist and expert in risk management and patient safety.
With nine years of experience as a member of the CPPSG, Giltrow's appointment represents a continuation of her longstanding dedication to advancing patient safety
initiatives within community pharmacy settings.
"It is crucial that patients can access care when they need it, whether from a pharmacist or a GP, " Paul Rees, Chief Executive of the National Pharmacy
Association (NPA) has said.
In response to a recent survey conducted by the General Medical Council (GMC) highlighting alarming trends among General Practitioners (GPs), the NPA has issued
a warning about the growing crisis in the UK's primary care system.
Rees emphasised the urgent need for government intervention, saying, "Only by reversing these cuts and providing pharmacies with a new funding deal will we be
able to end the 8am scramble for appointments."
The GMC survey reveals that there is a significant increase in the number of doctors reducing their working hours to safeguard their wellbeing, spotlighting
concerns about the long-term impact on patient care.
According to the report, nearly half of GPs ( 48 per cent) are struggling to manage their workload, with several resorting to decreasing their hours or declining
additional work to protect their mental and physical health.
Almost nine in ten community pharmacists in England say they have patients who sometimes go without prescription medicines because they cannot afford the
prescription charge levied by the government.
Sixty-eight per cent of pharmacists in a National Pharmacy Association (NPA) survey, conducted via email in June 2022, said this has become more frequent in the
past year - suggesting that the rising cost of living could be leading more people to miss out on vital medicines.
While prescription charge does not apply in Scotland, Wales and Northern Ireland, in England an NHS patients needs to pay £9.35 per item. For patients who need
multiples medicines the cost could be exponential and virtually unaffordable amid rising inflation and higher cost of living.
The survey found that 89 per cent of pharmacies in England have patients who sometimes go without prescription medicines due to cost.
For most pharmacists (74 per cent) this happens one to five times a week. Fifteen per cent said they see such patients from six to 20 times a week.
Two more independent community pharmacists have been appointed to the UK Commission on Pharmacy Professional Leadership.
NPA board member Reena Barai and Sheelin McKeagney from Lurgan in Northern Ireland will join 25 other commission members, including Ash Soni who was the only
practising community pharmacist on the initial list published in June.
Welcoming the announcement, the National Pharmacy Association chief executive, Mark Lyonette, said: "To their great credit, the co-chairs of the commission and the
UK's chief pharmaceutical officers have listened to our request for more community pharmacy presence on the commission. They have acted swiftly to achieve a better
balance in its membership and we thank them for responding to our representations.
"Around 70 per cent of pharmacists practice in the community. With more voices from community pharmacy within the leadership commission, there is a greater sense
that the profession as a whole will be able to own the final recommendations when they are ultimately made."
Community pharmacy could play an important role in proactive detection of heart valve disease (HVD), which remains under-recognised and under-detected in
England, suggested a new report published by Wilmington Healthcare.
Pharmacy bodies, including Royal Pharmaceutical Society (RPS), National Pharmacy Association (NPA) and Community Pharmacy England (CPE), have also endorsed the
report, which encourages Integrated Care Boards (ICBs) to consider the innovative approach of detecting HVD with the help of community pharmacists.
Despite HVD detection being a priority listed in the NHS Long Term Plan, a large number of people with HVD remained undiagnosed and untreated in the country due
to lack of awareness of the disease prevalence.
In June 2022, a pilot study was launched in Farnborough Primary Care Network (PCN), Hampshire, to evaluate the feasibility of using e-stethoscopes
(digital auscultation) to detect this heart condition by a community pharmacist.